Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-17 7:30 pm Sale |
2024-06-14 | 13G | IN8bio, Inc. INAB |
Orin Hirschman | 77,822 4.990% |
-58,790 (-43.03%) |
Filing History |
| 2024-08-19 06:03 am Purchase |
2024-08-16 | 13G | Personalis, Inc. PSNL |
Orin Hirschman | 4,394,064 6.700% |
1,394,064 (+46.47%) |
Filing History |
| 2024-07-26 12:56 pm Purchase |
2024-07-19 | 13G | Personalis, Inc. PSNL |
Orin Hirschman | 3,000,000 5.800% |
3,000,000 (New Position) |
Filing History |
| 2024-07-16 06:02 am Sale |
2024-07-15 | 13G | Red Cat Holdings, Inc. RCAT |
Orin Hirschman | 3,000,000 4.000% |
-2,026,104 (-40.31%) |
Filing History |
| 2024-06-11 4:05 pm Sale |
2024-06-10 | 13G | KWESST Micro Systems Inc. KWE |
Orin Hirschman | 0 0.000% |
-2,648 (Position Closed) |
Filing History |
| 2024-06-05 07:26 am Purchase |
2024-05-09 | 13G | Plus Therapeutics, Inc. PSTV |
Orin Hirschman | 568,681 9.900% |
568,681 (New Position) |
Filing History |
| 2024-05-30 08:42 am Purchase |
2024-05-16 | 13G | Arq, Inc. ARQ |
Orin Hirschman | 2,338,736 6.500% |
2,338,736 (New Position) |
Filing History |
| 2024-04-09 09:13 am Purchase |
2024-03-25 | 13G | Ideal Power Inc. IPWR |
Orin Hirschman | 700,000 9.500% |
700,000 (New Position) |
Filing History |
| 2024-04-09 08:49 am Purchase |
2024-03-25 | 13G | Intellicheck, Inc. IDN |
Orin Hirschman | 1,598,953 8.200% |
1,598,953 (New Position) |
Filing History |
| 2024-04-09 08:46 am Purchase |
2024-03-27 | 13G | Acasti Pharma Inc. ACST |
Orin Hirschman | 567,812 6.000% |
567,812 (New Position) |
Filing History |
| 2024-03-25 9:52 pm Sale |
2024-03-22 | 13G | Apyx Medical Corporation APYX |
Orin Hirschman | 0 0.000% |
-2,040,540 (Position Closed) |
Filing History |
| 2024-03-20 07:00 am Purchase |
2024-02-20 | 13G | Biofrontera Inc. BFRI |
Orin Hirschman | 501,434 9.900% |
501,434 (New Position) |
Filing History |
| 2024-02-21 06:01 am Sale |
2024-02-13 | 13G | BrainsWay Ltd. BWAY |
Orin Hirschman | 682,482 4.100% |
-356,046 (-34.28%) |
Filing History |
| 2024-02-13 06:34 am Purchase |
2024-02-09 | 13G | Evoke Pharma, Inc. EVOK |
Orin Hirschman | 70,583 9.990% |
70,583 (New Position) |
Filing History |
| 2024-02-07 7:16 pm Sale |
2024-02-07 | 13G | Biodesix, Inc. BDSX |
Orin Hirschman | 3,408,946 3.800% |
-2,159,955 (-38.79%) |
Filing History |
| 2024-02-07 7:01 pm Sale |
2024-01-30 | 13G | Cognition Therapeutics, Inc. CGTX |
Orin Hirschman | 1,448,270 4.800% |
-589,583 (-28.93%) |
Filing History |
| 2024-02-07 6:58 pm Purchase |
2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB |
Orin Hirschman | 88,744 8.700% |
24,903 (+39.01%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | LightPath Technologies, Inc. LPTH |
Orin Hirschman | 3,723,932 9.900% |
144,100 (+4.03%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Orin Hirschman | 349,300 11.000% |
4,300 (+1.25%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | Apyx Medical Corporation APYX |
Orin Hirschman | 2,040,540 5.900% |
156,259 (+8.29%) |
Filing History |